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TOWARD AN INTERNATIONAL
STANDARD OF SCIENTIFIC
INQUIRYt
George P. Smith, 1Ift
I. HUMAN RIGHTS AND THE NEW BIOTECHNOLOGY
UNTIL QUITE RECENTLY, the pervasive attitude among so-
phisticated observers in Australia, Europe and America has been
one of support for scientific inquiry and discovery. It was believed
that this progressive action was not only of overwhelming benefit to
society, but an essential attribute of human achievement and pro-
gress in the brave new world.' Subsequent agonizing reflections on
the horrors of the World Wars and the all too frequent limited con-
flicts since 1945, together sometimes with overly emotional con-
cerns regarding the full potential for nuclear, bacteriological and
chemical warfare and its very real potential for annihilating man-
kind, have witnessed a new and increasingly pessimistic tempera-
ment concerning scientific advancement. Indeed, it has been
recognized that "not all science is good for humanity."
2
The importance of human rights and its need to be recognized in
the era of the "New Biology" was underscored by initial efforts at
the United Nations in the 1970's.1 But before that activity, the 1948
Universal Declaration of Human Rights guarantees of "human dig-
t Editor's note: This article was the first article accepted for publication in this issue,
and was accepted in manuscript form in March, 1992. The editing of this article was
completed in August, 1992.
if Professor of Law, The Catholic University of America, Washington, D.C.
1. Mr. Justice Michael D. Kirby, Human Rights - The Challenge of the New Technol-
ogy, 60 AUSTRALIAN L. J. 170 (Mar. 1986). See Beth Gaze & Pascal Kasimba, Embryo Ex-
perimentation: The Path and Problems of Legislation in Victoria, in EMBRYO
EXPERIMENTATION 202 (Peter Singer et al. eds., 1990) for a comparative analysis of the laws
on embryo experimentation in the state of Victoria, Australia, one of the forerunners in the
field, as well as other countries). Gaze & Kasimba, supra, at 227-29. See also DIETER GIE-
SEN, INTERNATIONAL MEDICAL MALPRACTICE LAW: A COMPARATIVE LAW STUDY OF
CIVIL LIABILITY ARISING FROM MEDICAL CARE 750 (1988).
2. Kirby, supra note 1, at 171.
3. See idL at 174. See also RICHARD B. LILLICH & FRANK C. NEWMAN, INTERNA-
TIONAL HUMAN RIGHTS: PROBLEMS OF LAW AND POLICY (1979); Sheila Jasanoff, Biology
and the Bill of Rightvs Can Science Reframe the Constitution?, 13 AM. J. L. & MED. 249
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nity" written in Articles 1, 5, 6 and 29(1)1 established eloquent re-
minders of the need for the advances of biotechnology and genetic
engineering to be tied to a basic understanding of, and respect for,
fundamental human rights.5
A new human rights debate needs to emerge among not only the
legal community, but also among the scientists and technocrats; a
debate that would reconsider the extent to which both the tradi-
tional and the re-defined rights of humanity are challenged or com-
plemented by the plethora of medical, legal, scientific and
technological considerations of today's brave new world. Mr. Jus-
tice Michael D. Kirby of Australia succinctly summarized the issue:
"If lawyers are to continue to play a relevant part in the human
rights debate of the future, they must become more aware of scien-
tific and technological advances. Otherwise, they will increasingly
lack understanding of the questions to be asked, let alone the an-
swers to be given." 6
Law needs to direct an agenda for social change and changing
social needs rather than simply responding or reacting to change.
Indeed, former Chief Justice Warren E. Burger has observed, "The
law does not search out as do science and medicine; it reacts to
social needs and demands." 7 Law, science and medicine must be-
come partners. They must assure society today and tomorrow, that
all citizens have an equal opportunity to achieve their maximum
potential within the economic marketplace, have their physical suf-
(1987). The author delineates nine major policy areas under which seventeen situations may
arise that create constitutional controversies over the new biology. Id at 260-61.
4. G.A. Res. 217A (III), U.N. DOC A/810 at 71 (1948).
5. Kirby, supra note 1, at 179. Mr. Justice Kirby has cautioned that the increasing
knowledge of human fertility and its varied and mechanical applications draw new attention
to other human rights guarantees.
[Specifically] [clan Art. 16(1) of the Universal Declaration, with its guarantee that
men and women of full age have a right to marry and 'to found a family' provide
support for a claim to in vitro fertilization, embryo transplantation, artificial insemi-
nation, surrogate parenting and womb leasing, transplantation and the like? Is the
guarantee of special care and assistance for motherhood and childhood in Art. 25(2)
relevant to the new procedures available to overcome infertility? Is the guarantee of
adequate health and medical care in Art. 25(1) the basis for a claim of access with-
out limitation to these new techniques?
Id. See generally George P. Smith, II, The Razor's Edge of Human Bonding: Artificial Fa-
thers and Surrogate Mothers, 5 W. NEW ENG. L. REV. 639 (1983); George P. Smith, II, The
Perils and Peregrinations of Surrogate Mothers, 1 INT'L J. MED & LAW 325 (1982); George P.
Smith. II, Through a Test Tube Darkly: Artificial Insemination and The Law, 67 MICH. L.
REv. 127 (1968).
6. Supra note 1, at 181.
7. Justice Warren E. Burger, Reflections on Law and Experimental Medicine, in 1
ETHICAL, LEGAL AND SOCIAL CHALLENGES TO A BRAVE NEW WORLD 211, 211 (George
P. Smith, II ed., 1982).
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fering minimized and spiritual tranquility assured.'
The late Professor Thomas Emerson, a great civil libertarian,
cautioned in 1976 that one of the hard problems of the First
Amendment would soon be acknowledged as the extent to which
the state could recognize scientific research.9 As he observed
sagely, "It is hard to predict where these issues will lead."10 This
essay will explore the pathway where these issues are leading in
contemporary society.
Roots of the Modem Conflict
Long before Professor Emerson, Chief Justice Burger and Jus-
tice Kirby crystallized their ideas and their predictions, the epic
struggle of Galileo was played out and, as such, gave new direction
to how scientific freedom of expression would be allowed in 17th
century Catholic theology. 1
Galileo was censured by Pope Urban VIII in 1633 for averring
Copernicanism - the theory that put the sun at the center of the
solar system. Summoned to Rome to defend his book written the
previous year, DIALOGUE CONCERNING THE Two CHIEF WORLD
SYSTEMS, Galileo failed to sustain his case for free and unfettered
scientific inquiry. The views of Copernicus had been censured by
Rome in 1616 (even though he actually died in 1543) and, in that
same year, Galileo had been warned to cease his study and advo-
cacy of the Copernican theory. Originally condemned to life im-
prisonment for his views, Galileo's sentence was commuted by
Urban VIII to life-long house arrest thus enabling him to return to
Florence. 12
8. See generally SIR ZELMAN COWEN, REFLECTIONS ON MEDICINE, BIOTECHNOL-
OGY AND THE LAW (1986). See also Sidney A. Shapiro, Biotechnology and The Design of
Regulation, 17 ECOLOGY L.Q. 1 (1990); Hilaire Barnett, Biotechnology - Can the Law Cope?,
15 ANGLO-AM. L. REv. 149 (1986); Michael H. Shapiro, Introduction to the Issue Some
Dilemmas of Biotechnological Research, 51 S. CAL. L. REV. 987 (1987).
9. Thomas I. Emerson, Colonial Intentions and Current Realities of the First Amend-
ment, 124 U. PA. L. REv. 737 (1977). See also Loren R. Graham, Concerns About Science
and Attempts to Regulate Inquiry, DAEDALUS, Spring 1978, at 1.
10. Emerson, supra note 9, at 746-47.
11. See PIETRO REDONDI, GALILEO: HERETIC (1987).
12. Id. It has been suggested recently that Galileo's difficulty was not with his astron-
omy but his physics because 17th century Roman Catholic theology could more easily toler-
ate and live with the Copernican system, termed heliocentnism, than with a view of physics
whose atomism seemed to challenge the Eucharistic dogma that taught at Communion that
bread and wine were, ipsofacto, transubstantiated into Christ's body and blood. Id. See also
MICHAEL SEGRE, IN THE WAKE OF GALILEO 27 (1991) (Editor's note: this Article was
written and edited prior to the October 31, 1992 pardon of Galileo. For a discussion of this
19921
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Galileo's legacy is his animation of a movement designed to ad-
vance and, indeed, promote freedom of scientific expression. More
specifically as to his own case, Galileo fought against the intellec-
tual tyranny of what was termed Aristotelian scholasticism and
campaigned for the advancement of a new scientific language that,
in turn, would advance a basic right of research and free intellectual
discourse against what were prevarications of institutional
culture. 13
II. OPPORTUNITIES FOR THE NEW BIOLOGY
IN AMERICA
Modem scientific work is less a basic expression of the "ancient
aristocratic ethos of the love of knowledge" than a mere job to be
done by entrepreneurs, employees, or others who have independent
funding.14 In 1980, Genentech, a San Francisco based biotechnol-
ogy company, issued shares of its stock on the over-the-counter
market. Among its products are a hormone capable of stimulating
human growth, mass produced human insulin which would allow a
substantial reduction in cost of the treatment of diabetes, and in-
terferon which may prove to be the long awaited "miracle" drug to
combat cancer. The price of Genentech stock increased dramati-
cally during the first day of trading, and some brokers even sug-
gested that Genentech may in time be the next Polaroid or Xerox.I5
It has been asserted that patenting new forms of life, as sanc-
matter, see William D. Montalbano, Vatican Finds Galileo 'Not Guilty, WASH. POST, Nov. 1,
1992 at A40.).
13. Lauro Martines, The Trial of Galileo, WASH. POST, Dec. 13, 1987, (Book World), at
3. See also MICHAEL SEGRE, IN THE WAKE OF GALILEO (1991); Lynn White, Jr., Science
and The Sense of Self. The Medieval Background of a Modern Confrontation, DAEDALUS,
Spring 1978, at 47; CARL SAGAN, COSMOS 143 (1980).
14. John Compton, Science, Anti Science and Human Values, 1 AMICUS 33 (1980). See
generally, GEORGE P. SMITH, II, GENETICS, ETHICS AND THE LAW (1981).
15. Investors Dream of Genes, TIME, Oct. 20, 1980, at 72. While biotechnology stocks
have recently turned in uneven performances, and Genentech no longer seems to be the mar-
ket leader, this was not the case in the early 1980s. The potential profits derived from
manipulating the genetic code - be it either to create new forms of life sufficient to clean up
toxic chemical wastes or to produce anti-cancer agents on grand scale - spurred the then
President Derek Bok of Harvard University to suggest that his University start its own ge-
netic engineering firm. Strong faculty opposition, however, forced him to give up these plans.
A Firm No, TIME, Dec. 1, 1980, at 59. See GEORGE P. SMITH, II, THE NEW BIOLOGY: LAW,
ETHICS AND BIOTECHNOLOGY Ch. 1 (1989); IVER P. COOPER, BIOTECHNOLOGY AND THE
LAW (1987). See also J. Madeline Nash, A Bumper Crop of Biotech, TIME, Oct. 1, 1990, at 92;
Joan O'C Hamilton, Biotech: America's Dream Machine, Bus. WK., March 3, 1992, at 66;
Michael Waldholz & Hilary Stout, A New Debate Rages Over the Patenting of Gene Discover-
ies, WALL ST. J., April 17, 1992, at 1 (biotechnology will generate $50 billion in annual
revenue by the year 2000).
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tioned by the United States Supreme Court,16 will be guided by
short term profit motives rather than sound philosophical princi-
ples. 17 However, scientific knowledge is not, in and of itself, an ab-
solute end. The thrust and purpose of patenting new life forms are
basically technological and are essentially political. Because the eti-
ology of new life forms is political, both its costs and its benefits are,
of necessity, of public interest and concern.18
Pure scientific inquirydoes not produce an economic exploita-
tion of nature; only man's use of the truths of scientific inquiry does.
With the methodological style of nature, science seeks to demon-
strate causal relations among events. Thus, the laws of science state
that whenever X occurs or varies in a particular way, Y will simi-
larly occur or vary in a particular way. This phenomenon has been
aptly termed "a formula for action." Its practical application
awaits only an individual's decision that it might be economically
advantageous to try to mobilize X's to produce Y's. 19 Science
promises truth, not peace of mind.20 Yet liberty to extend knowl-
edge is never to be regarded as absolute - but rather as has been
seen, undergoes limitation when it conflicts with other values.2 '
The spirit of inquiry and analysis must focus as well on the addi-
tional parameters of the scientific imperative to explore truth; with
the reality of this inquiry being shaped in turn largely by the United
States patent laws and administrative interpretations and, more spe-
cifically, by the United States Supreme Court in its holding allowing
new forms of life created in a laboratory to be patented. The ulti-
mate purpose of this investigation is to refute the arrogance of
power theory expressed as being implicit in the current studies of
the vast potential for the positive achievement of good through har-
nessing the "New Biology." Thus, it will be demonstrated, that
what has been dismissed as but a magnificent obsession for power,
profits and immortality has, in truth, a far more intrinsic potential
16. Diamond v. Chakrabarty, 447 U.S. 303 (1980).
17. George J. Annas, Life Forms: The Law and the Profits, HASTINGS CENTER REP.,
Oct. 1978 at 21, 22. See also Stephen P. Stich, The Rewards and Risks of Studying Genes.
HASTINGS CENTER REP., April 1986, at 39. But see William Booth, Biomedical Scientists
Cite Funding 'Crisis, WASH. POST, June 29, 1990, at A25.
18. Compton, supra note 14, at 37.
19. Id.
20. See Philip J. Hilts, 'Rules'Drawn for Marketing Gene Research, WASH. POST, Mar.
28, 1982 at Al; George F. Will, The Spiral of Patents Pending, WASH. POST, June 22, 1980,
at D7.
21. Julius Stone, Knowledge, Survival, and the Duties of Science, 23 AM. U. L. REv. 231,
238 (1973).
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for good and reward for the scientific community and the greater
world community.
Improvement of man's genetic endowment by striving for posi-
tive propagation of those with a superior genetic make-up or, con-
versely, delimitation of those with negative genetic inheritance has
always been a primary concern in the field of genetics. 22 If the qual-
ity of life in some way may be improved or advanced by use of law
as it relates to genetics, then such must be undertaken. No longer
does the Dostoevskian quest to give life meaning through suffering
become an inescapable given. By and through new scientific ad-
vances in the field of genetics and successes with in vitro fertiliza-
tion, the real potential exists to prevent, in large measure, much
human suffering before it manifests itself in or through life.
Altering Human Evolution
Today, man is in a position not only to alter the social and envi-
ronmental conditions of the universe, but also to change his very
essence. The mythology of the Minotaur and the Centaur, half
man and half animal, may well become the reality of the twenty-
first century. Indeed, not only is modem medicine attempting to
create man-animal combinations, but also man-machine combina-
tions, or cyborgs.24 Plastic arteries, artificial limbs, and pacemakers
highlight the efforts of modem science to replace diseased or worn
out parts of the human body.25
Efforts to construct or engineer biologically functional bacterial
plasmids in vitro exemplify the relatively new technology of recom-
22. See GEORGE P. SMITH, II, GENETICS, ETHICS AND THE LAW 1 (1981). See also
Alexander M. Capron, Which Ills to Bear?: Reevaluating the "Threat" of Modern Genetics, 39
EMORY L.J. 665 (1990); George P. Smith, II, Eugenics and Family Planning: Exploring the
Yin and The Yang, 8 U. TASMANIA L. REV. 4 (1984).
23. JOSEPH FLETCHER, THE ETHICS OF GENETIC CONTROL: ENDING REPRODUCTIVE
ROULETTE (1974). See George P. Smith, II, Manipulating the Genetic Code: Jurisprudential
Conundrums, 64 GEO. L. J. 697 (1976). See also Sissela Bok, Freedom and Risk, DAEDALUS,
Spring 1978, at 115.
24. Barnaby J. Feder, The 'Pharmers' Who Breed Cows That Can Make Drugs, N.Y.
TIMES, Feb. 9, 1992, at F9 (animals artifically endowed with human genes may produce
hormones for drug companies such as Genpharm International, Inc. and DNX Corporation
within four years); Caryl Rivers, Genetic Engineering Portends a Grave New Word, SAT.
REV., April 8, 1972, at 23; Leon Jaroff, The Gene Hunt, TIME, Mar. 20, 1989, at 62. See
generally JUNE GOODFIELD, PLAYING GOD (1977); George P. Smith, II, Intimations of Im-
mortality: Clones, Cryons and The Law, 6 U. N.S.W. L. REv. 119 (1983).
25. See SMITH, supra note 15 at ch. 5; see Malcolm Gladwell, New Gene Therapy Proce-
dure Reportedly Done Within Body, WASH. POST, Sept. 14, 1990 at A17. See generally AR-
NOLD J. TOYNBEE, SURVIVING THE FUTURE (1971) and THE PROSPECTS OF WESTERN
CIVILIZATION (1949).
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binant DNA.26 Regarded as the most significant step in the field of
genetics since 1953, research in this technology will facilitate identi-
fication of every one of the 100,000 genes in the human cell. Armed
with this information, efforts could be directed toward replacing de-
fective genes with healthy ones. Thus, the hope is that by making
such replacements, genetic diseases such as hemophilia and sickle-
cell anemia could be conquered.27 Indeed, the plenitude of new
products of nature that could substantially improve the human con-
dition is staggering to the imagination.
The National Institute of Health (NIH) has taken a conservative
view of the limits of safety review required by those institutions re-
ceiving federal grant monies to experiment in DNA. In 1980, two
hundred representatives from the scientific community called upon
NIH to loosen the restriction on gene-splitting experiments con-
ducted in the United States. The scientists expressed the growing
agreement that DNA research carries fewer risks than had once
been thought.28
The central question which arises in relation to the current sci-
entific advances is whether genetic engineering should be promoted
and encouraged as a basic recognition of the freedom of scientific
inquiry and right of privacy. Significant potential dangers are pres-
ent in conjunction with the almost limitless opportunity for scien-
tific advancement within the technology of recombinant DNA,
commonly referred to as genetic engineering. The fear that the pro-
verbial "mad scientist," working independently or with an enemy
foreign power, could isolate and then proceed to duplicate a cancer
organism and possibly place it in public water supplies is not easily
dismissed. Acts of thoughtless negligence in a laboratory could re-
sult in the "escape" of a deadly microbe, which in turn could give
26. DNA is the basic genetic material that transmits inherited characteristics.
27. Matt Clark, Shannon Begley & Sharon Hager, The Miracle of Spliced Genes, NEWS-
WEEK, Mar. 17, 1980, at 62; See generally THE CODE OF CODES (Daniel J. Kevles et al. eds,
1992) (Scientific and Social Issues in the Human Genome Project and the possibility of DNA-
based medicine); Robert F. Baker & Wendy G. Clough, The Technological Use and Method-
ology of Recombinant DNA, 51 S. CAL. L. REv. 1009 (1978) (explaining the DNA process
and advances in genetic research).
28. Scientists Want Limit Dropped on Gene Splitting Experiments, WASH. POST, Nov.
26, 1980, at C3. But see, Cheryl M. Fields, Bizarre Circumstances Surround Chance Cloning
of Banner Virus, CHRON. OF HIGHER EDUc., Aug. 25, 1980, at 1, col. 1 (in violation of
federal guidelines that bar genetic copying, a researcher at the University of California at San
Diego cloned a virus); Irving Holtzman, Patenting Certain Forms of Life: A Moral Justifica-
tion, HASTINGS CENTER REP., June 1979, at 9 ; Rebecca S. Eisenberg, Patenting The Human
Genome, 39 EMORY L.J. 721 (1990). See also NIH May Accept Ban on Patenting Genes,
WALL ST. J. Aug. 27, 1992 at B4.
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rise to a "parade of horribles." Chance occurrences are always in-
herent in any scientific intervention.29 When the chance of harmful
accident is calculated, the primary consideration is whether the
merit of the intervention justifies beginning or continuing the
experiment.3 °
Genetic engineering, viewed as an instrument to revolutionize,
limits the effect of natural selection and replaces it with program-
med decision making. Programmed decision making facilitates,
rather than impedes, rational thinking. Is it shameful to acknowl-
edge that man has the capability to be in control of himself? The
lack of control over the years has spawned a type of "evolutionary
wisdom" which, in turn, resulted in the bubonic plague, smallpox,
yellow fever, typhoid, diabetes and cancer. Today, the quest for
maximum efficient utilization of biological and medical knowledge
represents one of the tenets of the so-called "evolutionary
wisdom."31
A number of Post-Darwinians in the scientific community assert
that there is no wisdom in evolution, only chance occurrence. Few,
if any, would be willing to accept unconditionally all that nature
bestows, particularly disease. Consequently, science finds itself in
the position of trying to both influence and, in many cases, control
the process of evolution. Some would go so far as to suggest that
dangerous knowledge is never half as dangerous as dangerous
ignorance.32
The sanctity of creation and the fundamental right of privacy in
procreation, which is an acknowledged basic or fundamental free-
dom, may be altered by compelling state interests.33 Is there a more
29. Robert Neville, Philosophic Perspectives on Freedom of Inquiry, 51 S. CAL. L. REV.
1115, 1128-29 (1978).
30. See generally Carl Cohen, Restriction of Research with Recombinant DNA: The
Dangers of Inquiry and The Burden of Proof, 51 S. CAL. L. REv. 1081, 1098 (1978); Mark W.
Lauroesch, Note, Genetic Engineering: Innovation and Risk Minimization, 57 GEO. WASH. L.
REv. 100 (1988).
31. Joseph Fletcher, Ethics and Recombinant DNA Research, 51 So. CAL. L. REv.
1131, 1139, (1978). Fletcher observes that there is nothing fundamentally unnatural or in-
trinsically wrong, or hazardous for the species, in the ambition that drives man to develop the
technology to understand himself. It would in fact seem more offensive to fall to use and
develop man's natural curiosity and talent for asking questions or worse to try to suppress it.
"This is the greater danger of our species, to try to pretend that we are another kind of animal
... and that the human mind can rise above its ignorance by simply asserting that there are
things it has no need to know." Lewis Thomas, Notes of a Biology Watcher: The Hazards of
Science, 296 NEw ENG. J. MED. 324, 328 (1977).
32. See Stephen Toulmin, Science and Ethics: Can They Be Reconnected, U. CHICAGO
MAG., Winter 1981, at 2.
33. See Roe v. Wade, 410 U.S. 113 (1973); George P. Smith, II, Procreational Auton-
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compelling state interest than the desire to stop a "chromosomal
lottery" which saddles the economy each year with four million
Americans born with diabetes or fifty thousand born with discerni-
ble genetic diseases?34 State interests in minimizing human suffer-
ing and maximizing the social good should be properly validated.35
Opponents of unrestricted genetic research specifically attack its
proponents as being both scientifically and socially irresponsible,
and the ultimate promoters of a serious environmental disaster.36
They suggest that nature has developed strong barriers against ge-
netic interchanges between species, and that extreme caution ought
to be used during experimentation in this area." Others argue that
mankind's genetic inheritance is its greatest and most indispensable
treasure which must be protected and guaranteed at any cost.
These opponents submit that the evolutionary wisdom of the ages
must not be irreversibly threatened or abridged in order to satisfy
the ambition and professional curiosity of some members of the sci-
entific community.
Autonomy, self-determination, and a basic sense of freedom
must be tempered by logic, objectivity, and a disinterested search
for knowledge; a search that may result in the minimizing of human
suffering and maximizing of social good.38 But what is the social
good in this question? It is suggested that the social good, within
this context, could be equated with an economic policy that lessens
the financial burden on citizens and supports and maintains geneti-
cally defective citizens. The wisest policy is, by consensus, that
which promotes a goodsocial, economic or otherwisefor the greatest
number. Thus, human need and well-being shape the degree of pos-
itive good resulting from one policy as opposed to another.39 Alter-
natively, a determination could be made in order to structure what
is right or wrong, good or evil, according to whether the conse-
quences of an act or public policy add to, or detract from, the aggre-
orny v. State Intervention: Opportunity or Crisis for a Brave New World?, 2 NOTRE DAME J. L.
ETHICS & PUBLIC PoL'Y 635 (1986); George P. Smith, II & Roberto Iraola, Sexuality, Pri-
vacy and The New Biology, 67 MARQ. L. REv. 63 (1984).
34. See Glass, The Effect of Changes in the Physical Environment on Genetic Change, in
GENETICS AND THE FUTURE OF MAN 43 (JOHN ROSHANSKY ed. 1966).
35. See SMrrH, supra note 14 at 2.
36. See generally TED HOWARD & JEREMY RIFKIN, WHO SHOULD PLAY GOD? (1977);
Philip J. Hilts, Genetic Scientist is Punished for Test Violations, WASH. POST, March 23, 1981,
at Al.
37. Robert L. Sinsheimer, Recombinant DNA - On Our Own, 26 BIOSCIENCE 599 (1976).
38. Robert L. Sinsheimer, Potential Risks, in RESEARCH WITH RECOMBINANT DNA
(National Academy of Science ed., 1977).
39. June Goodfield, supra note 24 at 71.
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gate human well-being.'
Ultimately, the decision for or against a policy is going to be tied
to development and maintenance of an a priori standard of ethics
(where, in theory, a balancing occurred before the standard was
set), or to a situational ethic by which the consequences, pro and
con, equities or inequities, of each proposed action will be carefully
weighed and a conclusion with an ethical posture or structure of a
standard of modus operandi41 will be reached.
Encouraging Experimentation
Recognizing that a sustained level of progress for society would
depend upon a continuing standard of technological evolution as
well as individual technological contributions of exceptional merit
and benefit, the Founding Fathers endeavored to codify this attitude
within the United States Constitution. By structuring a system of
checks and balances within the Constitution which would promote
both perspectives, contributions which were truly exceptional could
be promoted by grant of a limited monopolization as authorized by
the Patent Clause.42 However, the grant of limited monopolization
was intended to be consistent with the guarantees of the fifth and
the fourteenth amendments, that recognize the right of all citizens
to develop their individual skills in pursuit of a trade or calling, and
thus establish this right as an inalienable property right.43
There is a long history of efforts to legitimize monopolies for
patents of unworthy inventions. To its credit, the United States
Supreme Court has thwarted these efforts and has recognized and
enforced the Constitutional mandate to allow the unfettered growth
and natural evolution of technology.'
On June 16, 1980, by a 5-4 vote, the United States Supreme
Court decided that new forms of laboratory life were eligible for
40. See Fletcher, supra note 31, at 1131-39.
41. Id. at 1138-39.
42. See generally TOM L. BEAUCHAMP & LEROY WALTERS, CONTEMPORARY ISSUES
IN Bionmics (1978); George P. Smith, II, Uncertainties on the Spiral Staircase: Metaethics
and The New Biology, 41 THE PHAROS 10 (1978).
43. See Edward S. Irons & Mary Helen Sears, Patent 'Re-examination' A Casefor Ad-
ministrative Arrogation, 1980 UTAH L. REv. 287-88. By the Patent Clause, Congress is au-
thorized "[t]o promote the Progress of Science and useful Arts, by securing for limited Times
... Inventors the exclusive Right to their ... Discoveries". U.S. CONST. art. I, § 8, cl. 8.
44. See Sakraida v. Ag Pro, Inc., 425 U.S. 273, 279 (1976) (citing Graham v. John Deere
Co., 383 U.S. 1, 17 (1966)); Atlantic Works v. Brady, 107 U.S. 192, 200 (1882). Interestingly,
about 65-70% of litigated patents are invalidated. BEAUCHAMP & WALTERS, supra note 42,
at 305.
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patents.45 The decision may be regarded as a ratification of some of
the accomplishments of the "biological revolution" which has al-
lowed a broader understanding of life and promoted a greater abil-
ity to manipulate various forms. However, both the majority
opinion and the dissent stressed that they address only the question
of whether the current patent laws evinced a congressional intent to
deny patents to those inventions determined to be alive.46 More
particularly, the Court chose to tie itself to the United States Code
section which provides: "Whoever invents or discovers any new
and useful process, machine, manufacture, or composition of mat-
ter, or any new and useful improvement thereof, may obtain a pat-
ent therefor, subject to the conditions and requirements of this
title."47 Out of this statute emerged the issue of whether a manu-
factured microorganism constituted "a 'manufacture' or 'composi-
tion of matter' within the meaning of the statute. '48
Dr. Ananda M. Chakrabarty, a micro-biologist employed by the
General Electric Corporation, engaged in research in which he suc-
ceeded in manufacturing a new microorganism, not found in nature,
which is effective in breaking up oil spills. This genetically engi-
neered strain ofpseudomonas is made by combining (or cross breed-
ing) four strains of oil eating bacteria into one man-made
scavenging microorganism which combines the beneficial properties
of each of its four parent bacteria. Each of the four strains digest
particular hydrocarbons in a mixture of oil and water, such as is
found in petroleum spills. Useful by-products of water, carbon di-
oxide and bacterial protein which are nutritious to inhabitants of
the ocean, remain. Dr. Chakrabarty demonstrated that this manu-
factured "superstrain" is much more efficient in digesting oil than a
mixture of the four individual bacteria. Another advantage is that
this microorganism, if it "escaped," would not be able to thrive in
gas tanks or in the oil fields of the earth and wreak uncontrolled
45. Diamond v. Chakrabarty, 447 U.S. 303 (1980).
46. Justice Brennan, writing in dissent, surveyed the Patent Act of 1793, as re-enacted in
1952, the Plant Patent Act of 1920, and the Plant Variety Protection Act of 1970 and con-
cluded that there existed a strong congressional limitation against patenting bacteria. "It is
the role of Congress, not this Court, to broaden or narrow the reach of the patent laws. This
is especially true where, as here, the composition sought to be patented uniquely implicates
matters of public concern." Id. at 322. For those who have followed Justice Brennan's judi-
cial philosophy, this position, which calls for judicial restraint, is most interesting and unu-
sual. In the past, he has been the judicial activist and Chief Justice Burger the apostle of
judicial restraint. In Chakrabarty, the roles were reversed.
47. 35 U.S.C. § 101 (1976).
48. Diamond v. Chakrabarty, 447 U.S. at 307.
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environmental havoc on the ecosphere.49 The Chakrabarty bacte-
rium had already been granted a patent in Britain, which had fol-
lowed several European nations in recognizing both plants and
animals as patentable.5 0
The patent application of Chakrabarty and General Electric was
for a manufactured microorganism product not found in nature as
well as a process of using the microorganism, on a carrier, to digest
oil spilled in water. The United States Patent Office rejected the
product claim, but allowed a portion of the process claim. The ra-
tionale for rejection of the product claim was that a living organ-
isma naturally occurring product of natureas this was determined to
be, was not within the classes of subject matter which are patenta-
ble. The patent office reached this conclusion because there was no
mention of such a class in the controlling statute or in the statute's
legislative history. This decision was upheld by the Patent Office
Board of Appeals, but the United States Court of Customs and Pat-
ent Appeals reversed, and the Patent and Trademark Office ap-
pealed to the United States Supreme Court.51
In the past, the Patent Office has included living things within
the statutory subject matter. For example, in 1873, United States
Patent No. 141,072 was issued to Louis Pasteur. Claim two of the
patent application reads: "Yeast, free from organic germs of dis-
ease, as an article of manufacture."52 There are other examples, in
other patents, of claims having been granted for viruses and
cultures.53
Today, there are more than one hundred patent applications re-
lated to products of genetic engineering. 54 Chakrabarty sets the
49. Rick Gore, The Awesome Worlds Within a Cell, 150 NAT'L GEOGRAPHIC 355, 374-
75 (1976).
50. See generally Thomas D. Kiley, Common Sense and the Uncommon Bacterium - Is
'Life' Patentable?, 60 J. PAT OFF. Soc'y 468 (1978).
51. Application of Chakrabarty, 571 F.2d 40 (C.C.P.A. 1979) dismissed 439 U.S. 801
(1978) rev'd sub nom. Application of Bergy, 596 F.2d 952 (C.C.P.A. 1978), cert. granted, 444
U.S. 924 (1979). See Rebecca Dresser, Ethical and Legal Issues in Patenting New Animal
Life, 28 JURIMETRIcS 399 (1988).
52. Diamond v. Chakrabarty, 447 U.S. 308, 314 at n.9 (1980). See also Donald G.
Daus, Robert T. Bond & Shep K. Rose, Student Papers, Microbiological Plant Patents, 10
IDEA 87 (1966).
53. Id. at 94 n. 36. See Iver P. Cooper, Patent Protection for New Forms of Life, 38 FED.
BAR. J. 34 (1978); Rudolf F. Kip, Jr., The Patentability of Natural Phenomena, 20 GEO.
WASH. L. REv. 371 (1952).
54. See Donald D. Daus, Patents for Biotechnology, 26 IDEA 263 (1985-86); Marcia
Barinoga, Making Transgenic Mice Is it Really That Easy?, 245 SCIENCE 590 (1989); Wad-
dell A. Biggart, Patentability in the United States of Microorganisms, Processes Utilizing Mi-
croorganisms, Products Produced by Microorganisms and Microorganism Mutational and
[Vol. 2:167
SCIENTIFIC INQUIRY
pace for a wide variety of new "man-made organisms which can
facilitate socially desirable processes such as growing wheat in arid
lands, leeching ores to assist mining companies in reaching remote
part of the earth, and producing a "bug" that will ferment corn
starch or corn syrup into ethanol, an alcohol used in both whiskey
and gasohol. There is also a patent application for a bacterium that
metabolizes ethylene into ethylene glycol (antifreeze)."
As noted previously, the major thrust of the decision of the
United States Supreme Court in Chakrabarty is tied to the interpre-
tation of the term "manufacture" as it appears in the federal patent
code. Observing that Thomas Jefferson's Patent Act of 1793
stressed its coverage to "any new and useful art, machine, manufac-
ture, or composition of matter, or any new or useful improvement
[thereof)," Chief Justice Burger, writing for the majority, defined
manufacture as "the production of articles for use from raw materi-
als prepared by giving to these new materials new forms, qualities,
properties, or combinations whether by hand labor or by machin-
ery."56 Citing approving precedent defining "composition of mat-
ter" as including "all compositions of two or more substances...
all composite articles, whether they be the results of chemical
union, or of mechanical mixture, or whether they be gases, fluids,
powders or solids," the Chief Justice concluded that the
Chakrabarty microorganism qualifies as being within patentable
subject matter.5 7 The claim is particularly forceful since it is for a
product of human ingenuity which is non-natural in its
occurrence.
5 8
In response to the argument that microorganisms cannot be pat-
entable without express congressional authorization, Chief Justice
Burger declared that Congress had already defined what was pat-
entable subject matter in Section 101 of the Act, and that it was for
Genetic Modification Techniques, 22 IDEA 113 (1981-82). Some corporations have been quick
to market genetically engineered products. For example, DNA Plant Technology Corp. re-
ceived a patent for a genetically engineered celery, which it calls "Novel Celery Lines With
Increased Stick Yield." The patent has been licensed to Freshworld, DNA Plant Technology
Corp.'s branded-produce joint venture with Du Pont Co. for use in the Vegi Snax line of
snacking vegetables. DNA Plant Technology Corp., WALL ST. J., June 26, 1992 at B6.
55. See generally Dorothy Nelkin, Threats and Promises: Negotiating the Control of Re-
search, DAEDALUS, Spring 1978, at 191; Leslie Roberts, Ethical Questions Haunt New Ge-
netic Technologies, 243 SCIENCE 1134 (1989).
56. 447 U.S. at 308 (1980).
57. Id. at 308-309.
58. Id. at 310. See generally, Richard Delgado & Darrel R. Miller, God, Galileo and
Government: Toward Constitutional Protection for Scientific Inquiry, in 1 ETHICAL, LEGAL
AND SOCIAL CHALLENGES TO A BRAVE NEW WORLD 231 (George P. Smith, II ed., 1982).
19921
HEALTH MATRIX
the courts to define that provision. Finding no ambiguity in the
statutory provisions and stressing the broad constitutional and stat-
utory goal of promoting "the Progress of Science and the useful
Arts," Chief Justice Burger adhered to his position that the defini-
tion the Court gives to section 101 is consistent with the goals of the
Act.
59
The Court declined to acknowledge the "grave risks" or the
"gruesome parade of horribles" which the Patent Office argued that
the Court should weigh in deciding whether the Chakrabarty inven-
tion is patentable.' Although acknowledging that "genetic" re-
search and related technological developments may spread
pollution and disease, that it may result in a loss of genetic diver-
sity, and that its practice may tend to depreciate the value of life,"
the Court concluded that neither the grant nor the denial of patents
on microorganisms will end advance in genetic research nor "deter
the scientific mind from probing into the unknown any more than
Canute could command the tides."61 The Court stated unequivo-
cally that scientific arguments against advancements in this field are
matters of "high policy" which should be considered by the legisla-
tive process which balances and places in proper perspective the
various competing values and interests of all parties.62 The Chief
Justice concluded by noting that if the Court had misconstrued the
provisions of Section 101, all that Congress needed to do was to
amend the statute to exclude organisms which are produced by ge-
netic engineering from the protection of the patent laws.63
Despite the Court's disclaimer that its action was purely con-
structive in naturemerely an interpretation of a statutory mandateit
did attempt to validate a new national policy. While invoking the
Jeffersonian concept of ingenuity in patent creativeness, it came
down four-square on a policy encouraging experimentation into the
"New Biology" despite the possible risk to mankind. Thus, while
disclaiming the application of a balancing test, it, in effect, per-
formed one. It correctly decided that the utility of the good that
will flow from research and experimentation into the varied fields of
the "New Biology" far outweighs the potential harm accruing as a
consequence of such undertaking. This is an eminently fair and rea-
sonable position.
59. 447 U.S. at 315.
60. Id. at 316-317.
61. Id.
62. Id. at 317.
63. Id. at 311.
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A Further Innovative Application
In May, 1987, the United States Patent and Trademark Office
announced that it "considers non-naturally occurring nonhuman
multi-cellular living organisms, including animals, to be patentable
subject matter."" This policy was viewed by the Patent Office as an
effort to keep pace with the startling new advances in biotechnol-
ogy, and thereby encourage innovation and not determine its ethical
implications. Others, such as animal rights advocates, were con-
cerned that animals were being considered as products and not sen-
tient beings. 65 Some feared that the new policy would enable a
select number of biotechnology companies to dominate the livestock
industry, thereby eliminating small independent breeders and
threatening to eliminate genetic diversity among farm animals, 66
since with patents the central issue becomes who either owns, or is
in control of breeding livestock.67
Theologians quarrelled with the Patent Office policy because it
not only equated heavenly made creatures with manufactured goods
of the market place, but took a giant step on the slippery slope that
would lead to the patenting of genetically altered human beings and
man's full assumption of God-like powers. The clear specification
of the policy that its application was only for "nonhuman life" was
of no assurance here.6" Informed members of the scientific commu-
nity, however, saw the Patent Office as merely continuing the rea-
sonable exploitation of nature.69
The Transgenic Animal Patent Reform Act was passed in
1988.70 The Act excludes human beings from patentable subject
matter, provides immunity for patent infringement to farmers who
purchase patented farm animals and seek to reproduce them, and
also seeks to clarify the Patent and Trademarks Office's authority to
require biological materials deposits from patented animals.71 The
64. Claudia Wallis, Should Animals be Patented?, TIME, May 4, 1987, at 110. See also
TIM INGOLD, WHAT IS AN ANIMAL? (1988).
65. Id.
66. Id.
67. Id. See also Philip Elmer-Dewitt, The Perils of Trading on Heredity, TIME, Mar. 20,
1989, at 70-71.
68. Id.
69. Id.
70. Pub. L. 100-703, tit. II, § 201, 102 Stat. 4676, 35 U.S.C. § 271 (1988). See generally
Diana A. Mark, Comment, All Animals Are Equal, But Some Are Better Than Others: Patent-
ing Transgenic Animals, 7 J. CONTEMP. HEALTH L. & POLiCY 245 (1991).
71. House Passage ofAnimal Patent Bill, 36 Pat. Trademark & Copyright J. (BNA) No.
897 at 499 (Sept. 15, 1988). On March 22, 1989, Representative Robert Kastenmeier intro-
duced H.R. 1556, that would limit the rights of animal patentees beyond the restrictions
HEALTH MATRIX
most serious defect of this law is that it fails to define the term,
"human being." Thus, the extent to which genetic material consti-
tutes a human being is an open question.
"Should an animal that contains one-half of a human code be
considered human? How about one-quarter human genetic ma-
terial? Should genetically altered fetuses be considered patenta-
ble subject matter under current patent law? Although such
animals are not being patented .... such technology will exist in
the near future.",
72
It is expected that the near future of biotechnology will give rise
to work in laboratories in the United States where virus and bacte-
ria genes will be transferred to plants in an effort to enable them to
produce their own particular insecticides or fertilizers. After field
testing, these "transgenic" plants will be used by farmers in the
place of conventional crop varieties.73 Further successful research
will be undertaken that manipulates the primordial cells producing
sperm and eggs to enable breeders to determine the sex and other
preferred characteristics of their animals; and routine gene trans-
plants from one species to another will be accomplished routinely.74
As discussed previously,75 these and similar concerns over pat-
enting life were initially raised with the Chakrabarty decision.76
Since no catastrophic events have followed in the aftermath of
Chakrabarty, and none are expected from this new policy of the
United States Patent and Trademark Office, the on-going debates
over the long range effects of genetic engineering and its ethical con-
straints will be of little value in halting the momentum of scientific
inquiry, experimentation and advancement of biotechnology.
imposed on holders of conventional patents, with exemptions being granted to small family
farmers, certain larger farmers and researchers who reproduce these animals for non-com-
mercial purposes. His second Bill, H.R. 1557, seeks to regulate the use of genetically engi-
neered animals in agricultural activities (101st Cong., Ist Sess., 135 CoNG. REc. H830 (daily
ed., Mar. 22, 1989). Subsequently, H.R. 3247 was introduced on September 12, 1989, by
Representative Cardin that would impose a moratorium on the patenting of animal life until
a proper regulatory procedure is established. (101st Cong., 1st Sess., 135 CONG. REc. E3008
(daily ed., Sept. 12, 1989). Finally, Senator Mark Hatfield introduced S. 2169 in the Senate
on February 26, 1990, that seeks to set a five-year moratorium on granting transgenic animal
patents. (101st Cong., Ist Sess., 136 CONG. REc. S1611 (daily ed., Feb. 26, 1990).
72. 134 CONG. REc. H7439 (daily ed. Sept. 13, 1988), (Remarks of Rep. C. Rose).
73. Keith Schneider, A Patent on Life Forms Gets Genes Into Business, INTL. HERALD
TRIBUNE, June 9, 1987, at 1.
74. Id. See also, Robert S. Wasowski, The Evolution of Patentable Compositions of Mat-
ter: The United States Patent Office Accepts Genetically Altered Animals as Patentable Subject
Matter under 35 U.S.C. Section 101, 2 AD. L. J. 309 (1988).
75. See supra notes 18-41.
76. See generally Reagen Anne Kulseth, Note, Biotechnology and Animal Patents:
When Someone Builds a Better Mouse, 32 ARIz. L. RFv. 691 (1990).
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III. VALUES IN CONFLICT
Some would seek to abandon science and reason in favor of mys-
ticism, hermeneutics and transcendental rapture. Sadly, they fail to
comprehend that ignorance, not knowledge assures misery; and that
the employment of science for inhumane reasons, not science in and
of itself, threatens global survival. Reduced to its most fundamental
level, then, what is seen is that the pivotal questions confronting the
science of human experimentation are two in number: who will
control its products, and what purposes will be employed to achieve
this end.7
The improvement of human well-being has been, for the most
part, the single motivating force in the quest to ensure that all citi-
zens, especially young children, will be safe from all forms of dis-
ease; not only genetic and congenital disorders, but uterine
infections and a formidable host of other birth defects.78 Since the
1930s, for example, human fetal tissue has been an invaluable re-
search tool for molecular biologists as a source of human cell lines.
In turn, these cell lines have been widely used in advanced research
on viruses, and in the preparation of vaccines (notably, the polio
vaccine) against them. More recently, successful research has been
conducted on fetal tissue transplants in living subjects for therapeu-
tic purposes, and for developing treatments for Parkinson's disease,
diabetes and radiation-induced anemia. What makes fetal tissue
soparticularly useful for transplantation is the fact that it not only
grows rapidly and is very adaptable, but induces a limited immune
response from the host.
7 9
The Federal Position
Both as a response to Louise Brown's extracorporeal birth in
77. JOSEPH FRANCIS FLETCHER, HUMANHOOD: ESSAYS IN BIOMEDICAL ETHICS 93
(1979). See 1 ETHICAL, LEGAL & SOCIAL CHALLENGES To A BRAVE NEW WORLD, Ch. 10
(G. Smith ed. 1982); see also Commercialization of Biotechnology: Hearings Before the Sub-
comm. on Technology and Competitiveness of the House Comm. on Science, Space and Tech-
nology, 102 Cong., 1st Sess. 70-75 (1991) (statement of Lawrence Busch, Michigan State
Univ.).
78. Id. See also Eisenberg, infra note 114.
79. Henry Greely et al., The Ethical Use of Human Fetal Tissue in Medicine, 320 NEW
ENG. J. MED. 1093 (1989). It is between the sixth and eleventh weeks of gestation that nearly
eighty percent of all individual abortions are performed. Thus, neural and other tissue are at
a sufficiently developed state that it may-with success-be retrieved and transplanted. For
those abortions performed between fourteen and sixteen weeks, pancreatic tissue is of particu-
lar value in diabetes research. John A. Robertson, Rights, Symbolism and Public Policy in
Fetal Tissue Transplants, HASTINGS CENTER REP., December 1988, at 5.
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1978, and to a grant application for in vitro fertilization (hereinafter
"IVF") research, the then Department of Health, Education and
Welfare (now the Department of Health and Human Services) and
its Ethics Advisory Board decided to study the complex ethical,
legal, social and scientific issues raised by the IVF process. 80 The
final report of the Department was ultimately "buried in the bu-
reaucracy.""1 Yet today, given the sometimes strident pro-life
mood of a vocal segment of society, there is pessimism that a strong
positive movement will occur at the federal regulatory level.8 2 Due
largely to the leadership of former Congressman (now Senator) Al-
bert Gore of Tennessee, hearings were conducted in August, 1984,
on the issue of embryo transfers and the legal, ethical and medical
responses to such procedures.8 3 Although no firm or conclusive
steps were taken as a consequence of these hearings, they served to
focus attention on the need for continuing dialogue in this area.
Because of a de facto moratorium set in 1975, no federally
funded research has been undertaken on IVF.Y' Even though the
1979 Report of the Ethics Advisory Board of HEW concluded that
federal support of research on humans designed to establish the
safety and the effectiveness of IVF procedures would be ethically
permissible so long as certain conditions were met, 5 the Report has
never been accepted nor the moratorium ended; there is no real like-
lihood such action will be taken soon.8 6
It should be noted that the involvement of the federal govern-
80. Ethics Advisory Board of the Department of Health, Education and Welfare, Re-
port and Conclusions: HEW Support of Research Involving Human In Vitro Fertilization
and Embryo Transfer, 44 Fed. Reg. 35,033 (1979). See Richard A. McCormick, Who or
What is the Preembryo?, KENNEDY INST.. ETHics J., March 1991, at 1.
81. Harry D. Krause, Artificial Conception:L Legal Approaches, 19 FAM. L.Q. 185, 190
(1985).
82. This pessimistic, although realistic, view is tied to a perception that it would be far
better to hold in abeyance any strong movement at this time for fear of its possible linkage
with the right-to-life controversies and would thus give rise to the real possibility that it
would never be allowed to be evaluated in a calmer atmosphere. Susan Abramowitz, A Stale-
mate on Test-Tube Baby Research, HASTINGS CENTER REP., February 1984, at 5.
83. See Hearings On Human Embryo Transfer, Subcommittee on Investigations and
Oversight, US. House of Representatives' Committee on Science and Technology, 98th Cong.,
2nd Sess. 142 (1984).
84. Abramowitz, supra note 82.
85. Ethics Advisory Board, supra note 80 at 35,057. Among these conditions were that
the embryo be sustained in vitro beyond the implantation stage and that IVF, followed by
embryo transfer, be used only by married couples who had donated their sperm and ova.
Abramowitz, supra note 82.
86. Abramowitz, supra note 82 at 6. See John C. Fletcher & Kenneth J. Ryan, Federal
Regulations for Fetal Researck A Case for Reform, 15 L. MED. & HEALTH CARE 126
(1987).
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ment and its Department of Health and Human Services is pres-
ently structured by general regulations protecting human subjects
which apply to any IVF research, development, or other related ac-
tivities that might in the future be conducted by the Department, or
by the federal government outside the Department. 7 To ensure ad-
ditional protection in research projects that involve fetuses and/or
pregnant women, the Ethics Advisory Board of the Department
will be required to review every such proposal for IVF "as to its
acceptability from an ethical standpoint.""8
Subsequent specific protections have been provided to fetuses
who are the subject of proposed experimentation and IVF re-
search. 9 Although limited to research efforts funded in whole or in
part by the federal government, 9° these guidelines make a signifi-
cant distinction with regard to potential legal rights of implanted
embryos.9" The distinction is apparent in the definition of a fetus as
"the product of conception from the time of implantation (as evi-
denced by any of the presumptive signs of pregnancy, such as
missed menses, or a medically acceptable pregnancy test...).,92
As a consequence of this structured definition, research under-
taken on fetuses in utero and ex utero is prohibited unless the pur-
pose of the activity is to either meet the particular health needs of
the at-risk fetus, or there is minimal real or potential harm to the
fetus by the research, and the purpose is to obtain biomedical
knowledge not otherwise obtainable.93 Research undertaken on
non-viable fetuses ex utero is prohibited unless either vital functions
will not be maintained artificially, experimental activities that
would terminate vital functions are not used, or the research pur-
pose is to obtain otherwise unobtainable significant biomedical
knowledge. 94 The obvious implication of these restrictions on em-
bryonic and fetal research is that the scientific pursuit of mankind is
significantly handicapped. Private research into the mysteries and
the opportunities of the new reproductive biology continues. But,
87. 45 C.F.R. §§ 46.101-124, 46.301-306(g), 46.401-409 (1991).
88. 45 C.F.R. § 46.204(d) (1991). See also 45 C.F.R. § 46.205 (1991).
89. 45 C.F.R. §§ 46.102-206 (1985). In Vitro Fertilization is defined as "any fertiliza-
tion of human ova which occurs outside of the body of a female, either through admixture of
donor human sperm and ova or by any other means." Section 46.203(g) (1991).
90. 45 C.F.R. § 46.101(a) (1991).
91. Grace Ganz Blumberg, Legal Issues on Nonsurgical Human Ovum Transfer 251,
J.A.M.A. 1178 (1984).
92. 45 C.F.R. § 46.203(c) (1991).
93. 45 C.F.R. §§ 46.208(a) (1)-(2) (1991).
94. 45 C.F.R. §§ 46.209(b) (1)-(3) (1991).
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without a balanced regulator scheme and sources for federal re-
search funding, the initiative and the momentum for scientific ad-
vancement is curtailed.
The Bush Administration Extension
On November 13, 1989, the Bush Administration, through Dr.
Louis W. Sullivan, Secretary of Health and Human Services, ad-
vised the National Institutes of Health that, because of a belief that
allowing federal scientists to conduct research using fetal tissue
transplants would actually increase the incidence of abortion across
the country, the ban on fetal-tissue research would be extended.95
The Secretary stated that his department "should not be funding
activities which encourage or promote abortion." 96 Even though
limited in application to federal scientists, many members of the
medical research community are of the opinion that extension of the
fetal tissue research ban will produce a "chilling-effect" on this ex-
citing field of research even for privately funded undertakings.97
What is seen very clearly here is the inextricable relationship be-
tween abortion, fetal research9" and experimentation and, even
more importantly, a similar inextricability between politics and
morality.99
A British Response
A more sophisticated and enlightened position has been taken
by the British Government. In response to the findings of a na-
tional committee set up in 1988 to review guidelines for research use
of fetuses and fetal material, the British Health Minister announced
95. Michael Specter, Fetal-Tissue Research Ban Formally Extended, WASH. Posr, Nov.
3, 1989, at A5. (Editor's note: President Clinton has promised to lift the ban).
96. Id.
97. Id. See Michael Specter, Abortion Issue Chills Research: Fetal Tissue Fund Ban Side-
lines U.S. Experts, WASH. PoT, Mar. 27, 1990 at I; Ruth Marcus, Fetal Protection Policies;
Prudence or Bias?, WASH. POST, Oct. 8, 1990, at 1.
98. Id. Assistant Secretary of Health James 0. Madison at the Department of Health
and Human Services, told a congressional hearing April 1, 1990, that if the federal ban on
funding of medical research using fetal tissue were lifted, women would be encouraged to
have abortions. He observed that should the transplantation of fetal cells prove successful in
treating epilepsy, diabetes and Parkinson's disease, "additional rationalization of [for] di-
rectly advancing the cause of human therapeutics cannot help but tilt some already vulnera-
ble women toward a decision to have an abortion." Malcolm Gladwell, HUS Official
Defends Fetal-Tissue Policy, WASH. PoT, April 3, 1990, at A3.
99. George P. Smith, II, Procreational Autonomy v. State Intervention: Opportunity or
Crisis for A Brave New World? 2 NoTRE DAME J. LAW, ETHICS & PUB. POL'Y 635, 638
(1986). See generally, Richard Locayo, Pro Choice? Get Lost: Antiabortion Views Are a Must
at Health and Human Services, TIME, Dec. 4, 1989, at 43.
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that the Government had accepted the central recommendations of
the Committee which were issued July 26, 1989. °° Separating
abortion from the issue of how tissue from a dead fetus should be
used, the Committee recommended that separate maternal consent
be obtained for any act of abortion, and for the use of tissue from an
aborted fetus. No direct contact would be permitted either between
the abortion clinics or the institutions utilizing the tissue for re-
search.101 In an effort to safeguard against a possibility of "person-
ality transfer" between a fetus and the recipient of fetal brain tissue,
the recommendation was that in particular cases of nervous tissue,
"only isolated neurons or fragments of tissue should be used for
transplantation[s]." °2 The British Medical Association promptly
endorsed the recommendations and the government posture, ob-
serving that this policy was totally compatible with what the mem-
bers of the Association had freely "adopted covering physicians
responsible for carrying out abortions, as well as those using fetal
tissue to develop new therapies." ' 3
100. David Dickson, Fetal Tissue Transplants Win U.K. Approval, 245 SciENCE 464
(Aug. 4, 1989). See generally, BMA Guidelines on The Use of Fetal Tissue, THE LANCET,
(1988) at 1119 [hereinafter BMA Guidelines].
101. Dickson, supra note 100.
102. Id.
103. Id. The British Medical Association supports the following recommendations:
1. "Tissue may be obtained only from dead fetuses resulting from therapeutic or sponta-
neous abortion. Death of the fetus is defined as an irreversible loss of function of the organ-
ism as a whole.
2. UK laws on transplantation must be followed. The woman from whom the fetal
material is obtained must consent to the use of the fetal material for research and/or thera-
peutic purposes.
3. Transplantation activity must not interfere with the method of performing abortions,
nor the timing of abortions, nor influence the routine abortion procedure of the hospital in
any way. Abortion must be performed subject to the Abortion Act, and any subsequent
amendments thereof, uninfluenced by the fate of the fetal tissue. The anonymity of the donor
should be maintained.
4. The generation or termination of a pregnancy solely to produce suitable material is
unethical. There should be no link between the donor and the recipient.
5. There must be no financial reward for the donation of fetal material or a fetus.
6. Nervous tissue may be used only as isolated neurones or tissue fragments for trans-
plantation. Other fetal organs may be used as either complete or partial organs for transplan-
tation.
7. All hospital staff directly involved in the procedures-including the abortion-must
be informed about the procedures involved." Supra note 95, BMA Guidelines.
In a free-vote on April 25, 1990, the British Parliament endorsed the continued practice
of conducting in vitro medical and scientific research and experimentation on human embryos
up to 14 days of age. It is commonly understood that the appearance of the "primitive
streak" that represents the first physical embodiment of individuality, takes place the 14th
day after fertilization. Experiments on human cloning and hybridization (or the creation of
human-animal hybrids) were, however, outlawed. Michael White & Patrick Wintour, Britain
1992]
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Since, like it or not, abortion is legal, is it not a simple deduction
that it is ethically acceptable to use tissue from abortuses for re-
search?" °4 Rational, simple deductions are not the order of the day,
however, when dealing with issues that are so emotionally charged.
Inexplicable "feelings" and beliefs assume a mantle of sanctity not
countenanced in other logical areas of discourse. It is nevertheless a
legitimate act of faith to postulate that fetuses are persons.'0 5 The
only difficulty with such a position is that there is no absolute way
to prove or establish its validity. It can neither be verified nor
falsified. "°
A New Initiative?
Under a Bill entitled, "The National Institutes of Health Revi-
talization Amendments of 1991," introduced by Congressman
Henry A. Waxman on March 20, 1991, the moratorium on federal
funding of research on transplanting fetal tissue would be over-
turned. The bill provides that the National Institutes of Health, by
and through the authority of the Secretary of Health and Human
Services, would be given permanent authority to fund such re-
search, provided that it complies with strict ethical guidelines
prohibiting the sale of fetal tissues or directed donations. 0 7 The
proposed legislation would preclude the Secretary from issuing a
refusal to fund research determined to be scientifically valid on
purely ethical grounds, unless a special ethics advisory panel first
agreed that the research was unethical.08
Before research could be undertaken on donated human fetal
tissue, the woman providing the tissue must execute a written state-
ment acknowledging that the fetal tissue is being donated for use in
authorized research; that the donation is to be made without regard
to the identity of individuals who may ultimately be the recipients
of the tissue; and that the female donor has not been informed of
the identity of any recipients. In cases where tissue is provided as a
Gives The Go-Ahead for Embryo Research, 142 MANCHESTER GUARDIAN WKLY., April 29,
1990, at 1.
104. This was the initial posture taken by a review panel of the United States National
Institutes of Health and presented to the then Assistant Secretary for Health, Robert
Windom in 1988. Dickson, supra note 100.
105. Fletcher, supra note 77 at 96.
106. Id. See Smith, supra note 99; George P. Smith, II, Intrusions of a Parvenu: Science,
Religion and The New Biology, 3 PACE L. REv. 63 (1982); Robert L. Sinsheimer, The Pre-
sumptions of Science, DAEDALUS, Spring 1978, at 23.
107. H.R. 1532, 102nd Cong., 1st Sess. (1991).
108. Id. § 101.
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consequence of an induced abortion, the donor's statement must ac-
knowledge that the decision to donate is made independent of the
abortion decision, and not for the purposes of providing fetal tissue
for research. 109
If enacted into law, this proposed legislation would help to har-
monize the needs of science with individual human rights. With the
moratorium on fetal research and experimentation lifted, handi-
capped individuals with genetic or other disease, would no longer be
told that the cure for their disease is "too controversial to study" or
"too political to pursue."110
IV. TOWARD A STANDARD OF REASONABLENESS
The Supreme Court's actions in Chakrabarty, and the recent
Patent and Trademark policy on the patentability of nonhuman life,
give private corporations the incentive to invest further research
into the fields of bio-chemistry, genetics, and eugenics. This incen-
tive, and the anticipated result therefrom, satisfy the constitutional
objective of early disclosure which expands the public domain of
knowledge in these fields. There can be little doubt that patentabil-
ity of microorganisms and nonhuman life forms is "Progress of the
Useful Arts."
Man's dehumanization and depersonalization will not be fos-
tered as a consequence of the continued quest for mastery of the
genetic code, and the study and use of non-coital reproduction
processes. Attendant to the freedom to undertake research into the
exciting and fertile frontiers of the "New Biology" is a coexistent
responsibility to pursue the work in a reasonable and rational man-
109. Id. § 111. H.R. 1532 was substituted and replaced by H.R. 2507 amend the Public
Health Service Act to revise and extend the programs of the National Institutes of Health and
passed the House on July 25, 1991. The central focus of the replacement bill parallels the
original H.R. 1532. See CONG. REc. (daily ed. July 25, 1991) H5879. Senator Ted Kennedy
introduced S.B. 1523, parts of which in addition to dealing with NIH re-authorization, con-
sider ways to modify the ban on fetal experimentation. The Senate passed the measure 83-14
on June 4, 1992. However, it passed the House by only 260-148, short of the two-thirds
necessary to override a presidential veto. President Bush vetoed the measure on June 23,
1992 explaining he vetoed it "to prevent taxpayer funds from being used for research that
many Americans find morally repugnant and because of its potential for promoting and legit-
imizing abortion." Adam Clymer, Bush Vetoes Allowing U.S. To Fund Fetal-Tissue Study,
N.Y. TIMES, June 24, 199 at A13. Critics were quick to point out that politics had a lot to
do with the veto. Robert Bazell, Tissue Issue, THE NEW REPUBLIC, June 29, 1992 at 10
(Bush offering millions of sick and desperate Americans an "enduring civic lesson"); but see
Louis W. Sullivan, Good Reason for the Fetal-Tissue Research Ban, WASH. POST, Aug. 16,
1992 at C6 (Secretary Sullivan defends ban).
110. Sally Squires, NIH Chief Backs Fetal Research Ban, WAsH. PosT, April 16, 1991, at
5 (quoting Cong. Waxman).
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ner. Pursuing the "New Biology" in such a manner requires ade-
quate attention to the safety factor in all aspects of the
experimentation.11' The undesirable events of a Brave New World
can be tempered only when knowledge is pursued with the purpose
of establishing the truth and integrity of the question, issue, or pro-
cess. 112 The vast potentials for advancing society and ridding it of a
verisimilitude of its present ills is an obvious good which must be
steadily pursued. Little sustaining harm can result from a reason-
able pursuit of truth and knowledge; for, indeed, truth and knowl-
edge are the basic interstices in any balancing test. 1 3 If actions are
undertaken and performed with the goal of minimizing human suf-
fering and maximizing the social good, then the noble integrity of
evolution and genetic progress will be preserved.
So long as procreation continues to remain a central driving
force in a marital relationship and the family the very core of a
progressive society, efforts will be undertaken to expand the period
of fecundity and combat infertility. Genetic planning and eugenic
programming are more rational and humane alternatives to popula-
tion regulation than death by famine and war.
Man must endeavor to execute his investig.tory and manipula-
tive or creative powers within the scientific laboratory with a ra-
tional purpose and in a spirit of humanism. Man should seek to
minimize human suffering, thereby contributing to the social goal of
allowing each member of society an equal opportunity to achieve
their maximum output within the economic market place, and to
maintain personal integrity and seek spiritual tranquility. Genetic
engineering that contributes to the social good should be utilized
fully. There can be no real doubt that genetic manipulation pro-
vides a perilous opportunity that may either threaten freedom or
enhance it; depending upon the balance struck between its use for
11. Robert L. Sinsheimer, Paper "The Dawn of Genetic Engineering," at a meeting of
the Genetics Society of America, Chapel Hill, N.C., Aug. 17-20, 1975; 80 GENETICS 89
(1975) (abstract on file with HEALTH MATRIx), see also Sinsheimer supra note 106. But see
Roy D. Meridith, Comments, The Prospect of Private Unauthorized Eugenics and Ten Feet
Tall Basketball Players: A Case of Legislative Oversight?, 1 J. CONTEMP. HEALTH L. & POL'Y
155 (1985).
112. See George P. Smith, II, Manipulating the Genetic Code: Jurisprudential Conun-
drums, 64 GEO. L. J. 697 (1976). See also Karen Goodyear Krueger, Note, Building a Better
Bacterium: Genetic Engineering and the Patent Law After Diamond v. Chakrabarty, 81
COLUM. L. REv. 159 (1981).
113. Joshua Lederberg, Orthobiosi" The Perfection of Man, in PLACE OF VALUE IN A
WORLD OF FACTS 29 (Arne Tiselius & Sam Nilsson eds. 1980). See generally Bernard Fi-
carra, Twentieth Century Indicators of Change in American Medical Practices for the 21st
Century, 6 J. CoNTEMP. HEALTH L. & PoL'Y 1 (1990).
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individual need satisfaction and societal good. 114
Restraining scientific inquiry, to my way of analysis, should be
limited only to action considered to be unreasonable. Accordingly,
an undertaking would be regarded as unreasonable when the long
and short term costs of its effects would outweigh the enduring ben-
efits that would derive from its study and implementation. Viewed,
then, as being not only an aid to the tragedy of infertility in family
planning, but as a tool for enhancing the health of a nation's citi-
zens, vital scientific research must continue in the new, non-coital
reproductive technologies and in efforts to engineer man's genetic
weaknesses out of the line of inheritance. Healthier and genetically
sound individuals have a much better opportunity for pursuing and
achieving the "good life" and making a significant contribution to
society's greater well being.
114. See Michael D. Kirby, Bioethical Decisions and Opportunity Costs, 2 J. CONTEMP.
HEALTH L. & PoL'Y 7 (1986); David Baltimore, Limiting Science: A Biologist's Perspective,
DAEDALUS, Spring 1978, at 37; Leon Eisenberg, The Social Imperatives of Medical Research,
198 SCIENCE 1105 (1977). See generally GUSTAV JOSEPH VICTOR NoSsAL, HUMAN GE-
NETIC INFORMATION: SCIENCE, LAW AND ETHICS (1990).
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